Provides certolizumab drug concentration and anti-certolizumab antibodies in order to optimize treatment and facilitate clinical decision-making. This assay may be helpful in any patient on certolizumab therapy for Crohn's disease, psoriasis, or other autoimmune condition.
Immediately following collection, mix sample by gently inverting 5 times
Refrigerated (preferred) - 14 days
Frozen - 14 days
Freeze/thaw cycles: stable x 6
Ambient - 18 hours
Electrochemiluminescence Immunoassay (ECLIA); Surface Plasmon Resonance